CN Patent

CN107286134B — 2，4-二取代嘧啶衍生物作为cdk抑制剂及其应用

Assigned to CHENGDU JINRUI JIYE BIO-TECHNOLOGY CO LTD · Expires 2019-04-12 · 7y expired

What this patent protects

本发明涉及一类2，4‑二取代嘧啶衍生物、及其作为治疗上有效的周期蛋白依赖性蛋白激酶(CDK)抑制剂的应用。具体的，本发明涉及一种通式(I)所示的新的2，4‑二取代嘧啶衍生物、及其药物组合物，作为选择性CDK4/6抑制剂在预防或治疗与CDK4/6相关疾病中的用途。

USPTO Abstract

本发明涉及一类2，4‑二取代嘧啶衍生物、及其作为治疗上有效的周期蛋白依赖性蛋白激酶(CDK)抑制剂的应用。具体的，本发明涉及一种通式(I)所示的新的2，4‑二取代嘧啶衍生物、及其药物组合物，作为选择性CDK4/6抑制剂在预防或治疗与CDK4/6相关疾病中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN107286134B
Jurisdiction
CN
Classification
—
Expires
2019-04-12
Drug substance claim
No
Drug product claim
No
Assignee
CHENGDU JINRUI JIYE BIO-TECHNOLOGY CO LTD
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.